Nozomi Networks - The Pharmaceutical Industry and IT Security: A Review
2017 was a black year for the American pharmaceutical company Merck & Co. With almost 40 billion dollars in sales worldwide, Merck is one of the largest drug manufacturers in the world, and thus also an interesting target for cybercriminals.
But even Merck could not have imagined the sheer devastation that the global NotPetya ransomware attack would wreak on the company. An unheeded click on the attachment of an infected email sets up a Schaden 300 Millionen Dollar an – pro Quartal at Merck.
Because Industry 4.0 is also on the rise in the pharmaceutical industry - and with it an unprecedented networking of increasingly complex supply chains and the progressive merging of business IT and industrial OT systems.
At Merck, the NotPetya attack thus not only brings the company's day-to-day business to its knees, but also stops production, as OT machines are also infected by the ransomware. From an IT security point of view, this escalation of events represents the absolute worst case: NotPetya was smuggled into corporate networks through an infected attachment of a phishing email. The migration of the malware to the OT systems in Merck's production indicates a patchy networking of both network branches.
Unfortunately, Merck is not an isolated case. Again and again, cases of failed as well as successful cyberattacks on pharmaceutical companies become known. This was also the case with the bio-pharmaceutical company Charles River Laboratories, which announced in May 2019 that two months previously Opfer eines „hochversierten Hackerangriffs“ gewesen zu sein, the personal data of around 1% of the company's customers had been stolen.
The Charles River Laboratories case here paints another picture of the motivation for cyber-attacks on pharmaceutical companies - the targeted extraction of customer data or intellectual property. This information is not only interesting for professional cyber criminals, but also for nations such as China - keyword industrial espionage.
For example, shortly before the Charles River Laboratories press release, the German pharmaceutical giant Bayer AG announced that they too had Opfer einer Cyberattacke wurden, which was apparently coordinated from mainland China and designed to extract trade secrets.
For this very reason, pharmaceutical companies are often counted among the most vulnerable industries to cyberattacks. But how can proactive protection be ensured not only of IT but also of OT systems?
The American OT security specialist Nozomi Networks is aware of the problem: With "Guardian", Nozomi offers industrial customers in the MM/E segment an OT security solution that specialises in the early detection of malware attacks. "Guardian" does not intervene in the OT systems by itself, but Überwacht lediglich das System auf etwaige Anomalien. If an anomaly is detected, "Guardian" sounds an alarm and an incident response team can intervene immediately.